OBERWEIS ASSET MANAGEMENT INC/ - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 6 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
OBERWEIS ASSET MANAGEMENT INC/ ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2017$339,000
-90.4%
3,000
-91.5%
0.09%
-91.1%
Q1 2017$3,543,000
-41.0%
35,385
-36.6%
1.04%
-41.8%
Q4 2016$6,006,000
-23.8%
55,855
-11.8%
1.80%
-20.9%
Q3 2016$7,880,000
-10.5%
63,305
-23.5%
2.27%
-13.3%
Q2 2016$8,801,000
-14.7%
82,775
-8.1%
2.62%
-12.2%
Q1 2016$10,315,000
-14.7%
90,105
+6.1%
2.98%
-12.2%
Q4 2015$12,093,000
+113.7%
84,885
+34.7%
3.39%
+105.7%
Q3 2015$5,659,000
-8.1%
63,000
+17.8%
1.65%
+1.2%
Q2 2015$6,161,000
+14.8%
53,500
-4.8%
1.63%
+8.1%
Q1 2015$5,368,000
+59.7%
56,200
+12.4%
1.51%
+50.2%
Q4 2014$3,362,00050,0001.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2017
NameSharesValueWeighting ↓
SPQ Asia Capital Ltd 287,277$35,760,00028.32%
WARBURG PINCUS LLC 6,674$830,780,00013.45%
Ariose Capital Management Ltd 238,841$27,689,0007.56%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 12,600$1,568,0004.48%
RUDMAN ERROL M 37,001$4,606,0003.72%
INDUS CAPITAL PARTNERS, LLC 245,237$30,527,0002.89%
Ativo Capital Management LLC 93,784$11,674,0002.70%
OBERWEIS ASSET MANAGEMENT INC/ 63,305$7,880,0002.27%
Point72 Hong Kong Ltd 31,500$3,921,0002.14%
Cormorant Asset Management, LP 112,867$14,050,0001.55%
View complete list of CHINA BIOLOGIC PRODS INC shareholders